Vnitr Lek 2019, 65(4):326-334 | DOI: 10.36290/vnl.2019.058

Management of diabetic patients with lower extremity peripheral arterial disease

Peter Gavorník1, Andrej Dukát1,2, Ľudovít Gašpar1,3, Gabriela Gubo1, Naďa Bežillová1,4, Martina Kováčová5, Eva Gavorníková1,6, Anna Petrášová7, Iveta Gašparová1,8, Lujza Sabolová9,10, Marek Kučera3,11, Katarína Kusendová12, Alena Uhrinová1,3, Matej Bendžala1,13, Dáša Mesárošová3,10
1 Angiologická sekcia Slovenskej lekárskej komory (AS SLK), Slovenská republika
2 V. interná klinika LF UK a UNB, Nemocnica Ruřinov, Bratislava, Slovenská republika
3 I. interná klinika LF UK a UNB, Nemocnica Staré Mesto, Bratislava, Slovenská republika
4 III. interná klinika LF UK a UNB, Nemocnica akademika Ladislava Dérera, Bratislava, Slovenská republika
5 Národný ústav srdcových a cievnych chorôb (NÚSCH), Bratislava, Slovenská republika
6 Ambulancia všeobecného lekárstva pre dospelých, Poliklinika Ružinov, Bratislava, Slovenská republika
7 Lekáreň Salvator, Prosalute, Modra, Slovenská republika
8 Klinika telovýchovného lekárstva LF UK a UNB, Nemocnica Staré Mesto, Bratislava, Slovenská republika
9 Onkologický ústav sv. Alžbety (OÚSA), Bratislava, Slovenská republika
10 Slovenská zdravotnícka univerzita (SZU), Bratislava, Slovenská republika
11 Ambulancia všeobecného a vnútorného lekárstva, Vitacare, s.r.o., Modra, Slovenská republika
12 Národná transfúzna služba SR, Bratislava, Slovenská republika
13 Klinika infektológie a geografickej medicíny LF UK a UNB, Nemocnica akademika Ladislava Dérera, Bratislava, Slovenská republika

Extremitovascular arterial ischemic disease (lower extremity peripheral arterial disease - PAD) is an important manifestation of systemic atherosclerosis and other arterial diseases of vascular system. The lower the ankle-brachial pressure index, the greater the risk of serious acute instable organovascular events (e. g. acute myocardial infarction, stroke). Complex prevention and treatment of extremitovascular arterial disease is discussed in this article. Angiology/vascular medicine is the fastest growing field of internal medicine.

Keywords: angiology, vascular medicine; diabetology; extremitovascular artery disease; peripheral arterial disease (PAD); prevention; treatment

Received: April 26, 2018; Published: April 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gavorník P, Dukát A, Gašpar Ľ, Gubo G, Bežillová N, Kováčová M, et al.. Management of diabetic patients with lower extremity peripheral arterial disease. Vnitr Lek. 2019;65(4):326-334. doi: 10.36290/vnl.2019.058.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gavorník P. Angiológia 2 pre všeobecných praktických lekárov. Arteriológia. 1. vyd. Dr. Josef Raabe: Annecy-le-Vieux, Berlín, Bratislava, Budapešť, Praha, Sofia, Stuttgart, Varšava. 2014. ISBN 978-80-8140-168-8.
    2. Gerhard-Herman MD, Gornik HL, Barrett C et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017; 69(11): 1465-1508. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacc.2016.11.008>. Go to original source... Go to PubMed...
    3. Shah S, Antoniou GA, Torella F. Evidence-based analysis of peripheral arterial disease screening based on the WHO criteria. Int Angiol 2017; 36(4): 299-305. Dostupné z DOI: <http://dx.doi.org/10.23736/S0392-9590.17.03468-X>. Go to original source... Go to PubMed...
    4. Fowkes GF, Forster RB, Levin CE et al. Priorization of treatments for lower extremity peripheral artery disease in low- and middle-income countries. Int Angiol 2017; 36(3): 203-215. Dostupné z DOI: <http://dx.doi.org/10.23736/S0392-9590.16.03716-0>. Go to original source... Go to PubMed...
    5. Lawall H, Huppert P, Espinola-Klein C et al. German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016. Vasa 2017; 46(2): 79-86. Dostupné z DOI: <http://dx.doi.org/10.1024/0301-1526/a000603>. Go to original source... Go to PubMed...
    6. Gavorník P, Holomáň M, Kolesár J et al. Kinezioterapia ischemickej choroby dolných končatín u chorých po rekonštrukčnej operácii tepien. Čas Lék Česk 1986; 125(32): 1000 1003. Go to PubMed...
    7. Gavorník P, Kolesár J, Dukát A. Pohybová liečba (kinezioterapia) ischemickej choroby dolných končatín III. štádia. Vnitřn Lék 1986; 32(6): 597-604.
    8. Gavorník P, Kolesár P, Hudec I et al. Význam kinezioterapie ischemickej choroby dolných končatín u chorých s rodinnými hyperlipoproteinémiami. Vnitřn Lék 1981; 27(1): 72-79.
    9. Gavorník P. Ateroskleróza a iné choroby tepien. 1. vyd. Univerzita Komenského - Vydavateľstvo UK: Bratislava 1999. ISBN 80-223-1422-6.
    10. Gavorník P, Dukát A, Gašpar Ľ. Manažment dyslipidémií - prítomnosť a budúcnosť. Odporúčania Sekcie angiológov Slovenskej lekárskej komory (2013). Vnitř Lék 2013; 59(10): 932-938. Go to PubMed...
    11. Gavorník P, Dukát A, Gašpar Ľ et al. Antitrombocytová tromboprofylaxia artériových vaskulárnych chorôb a orgánovaskulárnych ischemických chorôb. Vnitř Lék 2017; 63(2): 124-132. Go to original source... Go to PubMed...
    12. Gavorník P, Dukát A, Gašpar Ľ et al. Súčasné registrované a kategorizované antihypertenzné liekové dvojkombinácie v Slovenskej republike. Ateroskleróza 2017; 21: 1037-1044.
    13. Gavorník P. Obliterujúce choroby artérií a končatinovocievna ischemická choroba. Nová klinicko-etiologicko-anatomicko-patofyziologická klasifikácia. Kardiológia/Cardiology (Cardiol Lett) 2010; 19(3): 201-213.
    14. Gavorník P, Dukát A, Gašpar Ľ et al. Choroby aorty - diagnostika, klasifikácia a princípy manažmentu. Kardiol Rev Int Med 2014; 16(6): 493-500.
    15. Liu Y, Wu F, Lu L et al. Examination of the Retina. N Engl J Med 2015; 373(8): e9. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMvcm1308125>. Go to original source... Go to PubMed...
    16. Warkentin TE. Ischemic Limb Gangrene with Pulses. N Engl J Med 2015; 373(7): 642-655. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1316259>. Go to original source... Go to PubMed...
    17. Werner C, Laufs U. Moving beyond the "LDL hypothesis". Vasa 2015; 44(5): 333-340. Dostupné z DOI: <http://dx.doi.org/10.1024/0301-1526/a000451>. Go to original source... Go to PubMed...
    18. Husmann M, Jacomella V, Thalhammer C et al. Markers of arterial stiffness in peripheral arterial disease. Vasa 2015; 44(5): 341-348. Dostupné z DOI: <http://dx.doi.org/10.1024/0301-1526/a000452>. Go to original source... Go to PubMed...
    19. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38(1): 140-149. Dostupné z DOI: <https://doi.org/10.2337/dc14-2441>. Go to original source... Go to PubMed...
    20. Fox CS, Golden SH, Anderson C et al. [American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association]. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care 2015; 38(9): 1777-1803. Dostupné z DOI: <http://dx.doi.org/10.2337/dci15-0012>. Go to original source... Go to PubMed...
    21. Yoshitaka I, Suzuki H. Exercise therapy for intermittent claudication in peripheral artery disease. E-Journal of Cardiology Practice (ESC) 2015; 13(34). Dostupné z WWW: <https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease>.
    22. Reith C, Armitage J. Management of residual risk after statin therapy. Atherosclerosis 2016; 245: 161-710. Dostupné z DOI: <http://doi:10.1016/j.atherosclerosis.2015.12.018>. Go to original source... Go to PubMed...
    23. Gavorník P, Dukát A, Gašpar Ľ et al. Prevencia a liečba končatinovocievnej ischemickej choroby. Vnitř Lék 2010; 56(6): 613-619. Go to PubMed...
    24. Informácie dostupné z WWW: <http://www.esvm-prague.org/>.
    25. Informácie dostupné z WWW: <http://www.angiology.org/events/iua-events>.
    26. Ridker PM, Everett BM, Thuren T et al. for the CANTOS Trial Group. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017; 377(12): 1119-1131. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1707914>. Go to original source... Go to PubMed...
    27. Eikelboom JW, Connolly SJ, Bosch J et al. [COMPASS Investigators]. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med 2017; 377(14): 1319-1330. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1709118>. Go to original source... Go to PubMed...
    28. Barrett EJ, Liu Z, Khamaisi M et al. Diabetic Microvascular Disease: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab 2017; 102(12): 4343-4410. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2017-01922>. Go to original source... Go to PubMed...
    29. Sabatine MS, Giugliano RP, Keech AC et al. [FOURIER Stering Committee and Investigators]. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Eng J Med 2017; 376(18): 1713-1722.Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1615664>. Go to original source... Go to PubMed...
    30. Martinka E, Uličiansky V, Mokáň M et al. Konsenzuálne terapeutické odporúčanie Slovenskej diabetologickej spoločnosti pre diabetes mellitus 2. typu (2018). Interná med 2018; 18 (1): 31-47.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.